ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 154 filers reported holding ACORDA THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $897,000 | -2.8% | 45,531 | +3.6% | 0.35% | +17.3% |
| Q1 2017 | $923,000 | +37.6% | 43,957 | +67.2% | 0.30% | +143.9% |
| Q2 2016 | $671,000 | +137.9% | 26,290 | +146.9% | 0.12% | +200.0% |
| Q1 2016 | $282,000 | -28.6% | 10,647 | -28.6% | 0.04% | +7.9% |
| Q3 2015 | $395,000 | -77.4% | 14,911 | -71.5% | 0.04% | -77.6% |
| Q2 2015 | $1,745,000 | -12.9% | 52,360 | -13.1% | 0.17% | -13.3% |
| Q1 2015 | $2,004,000 | -55.4% | 60,227 | -45.2% | 0.20% | -54.3% |
| Q4 2014 | $4,492,000 | +51.2% | 109,905 | +25.3% | 0.43% | +66.9% |
| Q3 2014 | $2,971,000 | +167.7% | 87,706 | +166.5% | 0.26% | +195.4% |
| Q2 2014 | $1,110,000 | +131.7% | 32,916 | +160.8% | 0.09% | +171.9% |
| Q1 2014 | $479,000 | -44.9% | 12,622 | -57.6% | 0.03% | -22.0% |
| Q4 2013 | $869,000 | +3.1% | 29,774 | +16.5% | 0.04% | +17.1% |
| Q2 2013 | $843,000 | – | 25,550 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |